ライフサイエンスコーパス: MPA

1 MPA (P < .005) and dexamethasone (P < .01), but not NET-

2 MPA affected intracellular nucleotide levels, nucleotide

3 MPA clearance was higher than in women with HIV not on A

4 MPA clearance was higher than in women with HIV not on A

5 MPA exposure increased intracellular concentrations of f

6 MPA PK parameters were calculated using non-compartmenta

7 MPA PK parameters were calculated using noncompartmental

8 MPA significantly altered 35 proteins mainly related to

9 MPA treatment interferes with transcription elongation,

10 MPA treatment of Huh7 cells could suppress autophagy, ev

11 MPA treatment of infected mice resulted in 50% mortality

12 MPA was associated with inhibited cell proliferation and

13 MPA was computed as 200 cGy/DTotal for each DTotal estim

14 MPA, but not NET-A, subverts mycobacterial containment i

15 cretion in TDC cultures fourfold (P < 0.05); MPA reduced this effect.

16 Consequently, correlation with method 1 MPA was strongest for method 2 MPA (r = 0.99) and weakes

17 with method 1 MPA was strongest for method 2 MPA (r = 0.99) and weakest for method 4 (r = 0.

18 gement and fish population data (433 and 218 MPAs, respectively) to assess: MPA management processes;

19 Colloidal 3-mercaptopropionic acid (3-MPA) capped lead sulfide quantum dots were prepared in a

20 te the effect of 3-mercaptopicolinic acid (3-MPA), a PEPCK inhibitor, on C2C12 muscle cells.

21 3-MPA inhibited PEPCK-M enzyme activity as 3-MPA interfered with the PEPCK enzyme assay, particularly

22 iation was significantly induced following 3-MPA treatment (0.25, 0.5, 1 mM) from day 0 of differenti

23 in a dose-dependent manner following 48 h 3-MPA treatment (0.01-1 mM).

24 High doses (0.5 and/or 1 mM) of 3-MPA reduced mRNA expression of Pck2 and genes associated

25 However, we were unable to confirm that 3-MPA inhibited PEPCK-M enzyme activity as 3-MPA interfere

26 isoform in C2C12 cells, we postulate that 3-MPA promoted myogenic differentiation through the inhibi

27 MPO- or PR3-ANCA-positive patients with AAV (MPA and GPA) and severe kidney disease (eGFR <30 ml/min

28 25 mg/day) plus medroxyprogesterone acetate (MPA) (<10 mg/day) or oral CEE alone and cardiovascular d

29 /- 10(-7) mol/L medroxyprogesterone acetate (MPA) +/- 1 IU/mL thrombin pretreatment for 4 hours, wash

30 estrogens plus medroxyprogesterone acetate (MPA) among participants with an intact uterus were carri

31 lus 2.5 mg/d of medroxyprogesterone acetate (MPA) and 8102, placebo.

32 Medroxyprogesterone acetate (MPA) and dydrogesterone (DDG) are synthetic progestins w

33 contraceptives, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A), on host suscept

34 r 2 d or E2 and medroxyprogesterone acetate (MPA) for 6 d.

35 at clearance of medroxyprogesterone acetate (MPA) would increase when given with rifampicin and efavi

36 termine whether medroxyprogesterone acetate (MPA), a progestin drug, is chemopreventive.

37 ith TFV or TAF, Medroxyprogesterone acetate (MPA), but not Levonorgestrel, Norethisterone or progeste

38 .625 mg/d) plus medroxyprogesterone acetate (MPA, 2.5 mg/d) (n = 8506) vs placebo (n = 8102) for 5.6

39 ed for 6 wk with methylprednisolone acetate (MPA), a synthetic glucocorticoid.

40 tric acid (CA) and 3-Mercaptopropionic acid (MPA) and characterized through advanced techniques.

41 rochloride (Cyst), 3-Mercaptopropionic acid (MPA), 11-Mercaptoundecanoic acid (MUDA) and 11-amino-1-u

42 d with the help of 3-mercaptopropionic acid (MPA)-capped CdSe quantum dot (MPA-CdSe QD) and visible l

43 d from day 5 according to mycophenolic acid (MPA) exposure (arm A) or a regimen with CS maintained up

44 s studies have shown that mycophenolic acid (MPA) has an anti-HCV activity.

45 Mycophenolic acid (MPA) is the active immunosuppressive substance in both m

46 Mycophenolic acid (MPA) is the active metabolite of mycophenolate mofetil,

47 g the negative effects of mycophenolic acid (MPA) on human intestinal cells.

48 ("one-dose-fits-all"), to mycophenolic acid (MPA) trough concentration monitoring, to dose optimizati

49 teroids and alternatively Mycophenolic Acid (MPA, n=38) or mTORi (either everolimus or sirolimus, n=3

50 teroids and alternatively mycophenolic acid (MPA; n = 38), or mTORi (either everolimus or sirolimus,

51 r (S)-alpha-methoxy-alpha-phenylacetic acid (MPA) or (S)-phenylglycine methyl ester (PGME) linked thr

52 osphonate (DMMP) and methyl phosphonic acid (MPA) exhibit the reduced mobility values of 1.99 +/- 0.0

53 nolate mofetil [MMF], and mycophenolic acid [MPA]), but not obatoclax or Osu-03012, showed potent ant

54 in the density of membrane-proximal F-actin (MPA) during membrane protrusion and cell migration.

55 radiation, the maximum permissible activity (MPA) of (131)I to treat thyroid cancer is that which lim

56 In addition, MPA Portable now supports state-of-the-art database sear

57 how ecological and physical contexts affect MPA performance.

58 Although MPA treatment can activate p53, this is not required for

59 networks of MPAs operate if the space among MPAs is smaller than the dispersal capacity of the speci

60 ssay based on Multiplex Probe Amplification (MPA) technology.

61 ation monitoring, to dose optimization to an MPA exposure target (as area under the concentration-tim

62 an quantify increases in flow in the AAo and MPA during strenuous exercise and is highly repeatable.

63 For flow measurements in the AAo and MPA, relative differences between observers never exceed

64 electrostatic interaction between DOTAP and MPA layer during the formation of DOPE-DOTAP-AuNP (DDA)

65 impacting marine protected areas (MPAs) and MPA networks, yet adaptation strategies are rarely incor

66 cases, which makes TBBA superior to MTPA and MPA and comparable to 9-AMA.

67 ionships between the level of protection and MPA size, age, and enforcement.

68 nts, referred to determine (131)I uptake and MPA for initial treatment after thyroidectomy (n = 39),

69 nces have revealed the medial preoptic area (MPA) as a key site for the regulation of torpor in mice.

70 st entirely high seas marine protected area (MPA) in 2010.

71 In an old marine protected area (MPA), invasion of S. horneri was suppressed, likely due

72 formation (constituting a medial place area [MPA]), whereas anterior aspects process information that

73 creasingly impacting marine protected areas (MPAs) and MPA networks, yet adaptation strategies are ra

74 No-take marine protected areas (MPAs) are a commonly applied tool to reduce human fishin

75 Marine protected areas (MPAs) are a cornerstone of marine conservation.

76 Marine protected areas (MPAs) are conservation tools that are increasingly imple

77 Marine protected areas (MPAs) are increasingly being used globally to conserve m

78 Networks of marine protected areas (MPAs) often aim to maintain connectivity, but anticipati

79 the global system of marine-protected areas (MPAs) represents individual species and the breadth of e

80 oal for establishing marine protected areas (MPAs) to conserve the ocean's biodiversity was set in 20

81 ility, large no-take marine protected areas (MPAs) with pelagic components are being implemented.

82 ncluding creation of marine protected areas (MPAs), reef restoration projects, and assisted evolution

83 ment fully protected marine protected areas (MPAs).

84 s and its network of marine protected areas (MPAs).

85 ions associated with Marine Protected Areas (MPAs).

86 such as networks of marine protected areas (MPAs).

87 cal system called a Magnetic Pendulum Array (MPA).

88 comprehensive human membrane protein array (MPA).

89 tion with the dilated main pulmonary artery (MPA).

90 nding aorta (AAo) and main pulmonary artery (MPA).

91 (433 and 218 MPAs, respectively) to assess: MPA management processes; the effects of MPAs on fish po

92 In contrast to the original server-based MPA application, this newly developed tool no longer req

93 Because MPA based on blood measurements alone is comparable to M

94 An accurate accelerated design of bis-MPA monomers with orthogonally complementary moieties an

95 ber and coverage of MPAs are increasing, but MPA implementation lags in many human-dominated regions.

96 ults reveal that suppression of autophagy by MPA plays a role in its anti-HCV activity.

97 pression of three autophagy-related genes by MPA involves in its antiviral mechanism.

98 and Atg7 were identified to be inhibited by MPA treatment.

99 partly recover HCV replication inhibited by MPA; however, silencing their expression by siRNAs could

100 followed by death were increased with CEE + MPA but not with CEE.

101 ath were reduced with CEE but not with CEE + MPA, and those for hypertension followed by death were i

102 trogens and medroxyprogesterone acetate (CEE+MPA) resulted in increased risk of coronary heart diseas

103 and 431 participants in the WHI CEE and CEE+MPA trials, respectively.

104 olites were not significantly changed by CEE+MPA.

105 n the direction of increased CHD risk by CEE+MPA; the remaining 11 metabolites were not significantly

106 , for myocardial infarction, results for CEE+MPA were in the direction of risk elevation in WHI and i

107 initiation, associations of CEE alone or CEE+MPA with most clinical outcomes were highly concordant b

108 ts that generally favored CEE alone over CEE+MPA in term of CHD risk.

109 changed with randomized CEE and 52% with CEE+MPA (false discovery rate-adjusted P value<0.05) in mult

110 ch was high in the front of migrating cells, MPA density was low in the front and high in the back.

111 imulated peripheral blood mononuclear cells, MPA and dexamethasone, but not NET-A, upregulated (media

112 In contrast, with genital CD4+ T cells, MPA suppressed TAF inhibition of HIV infection and lower

113 (as area under the concentration-time curve [MPA AUC0-12]).

114 s not completely characterized how to design MPAs under diverse ecological and economic conditions wh

115 ll as an important aspect of reserve design (MPA size) into a general model and determined their comb

116 es, in the context of managing and designing MPA networks, may ensure that conservation goals are ach

117 ghts and quantitative guidance for designing MPAs for food security in open-access fisheries.

118 rements alone are sufficient for determining MPA.

119 ons and progesterone were measured pre-dose (MPA only), 2, 4, 6, 8, 10 and 12 weeks after a single DM

120 ropionic acid (MPA)-capped CdSe quantum dot (MPA-CdSe QD) and visible light.

121 cubated in control medium with estradiol +/- MPA.

122 r the designation and management of European MPAs.

123 ented, with growing national commitments for MPA expansion.

124 re 8.72 +/- 2.93 and 7.85 +/- 3.07 ng/mL for MPA and mTORi group respectively, P = 0.277).

125 re 8.72 +/- 2.93 and 7.85 +/- 3.07 ng/ml for MPA and mTORi group respectively, P=0.277).

126 Recommendations for MPA management were more unified and focused on adaptati

127 Although the primary push for MPAs has been to solve the conservation problems that ar

128 Food security benefits from MPAs can be obtained from species of any mobility.

129 Back-to-front MPA density gradients were controlled by higher cofilin-

130 d global effort to adapt existing and future MPA networks to continued climate change.

131 f knowledge for adapting existing and future MPAs to climate change and synthesize case studies (n =

132 We also estimate that the current global MPA system secures only 1.7% of the Tree of Life for cor

133 strategically expanding the existing global MPA network to protect an additional 5% of the ocean cou

134 and at a 2-propanol flow rate of 160 muL/h, MPA demonstrated the greatest shift in mobility (1.58 cm

135 Five women (11.9%; 95% CI, 4.0-25.6%) had MPA <0.1 ng/mL at week 12; of these, one had MPA <0.1 ng

136 Five women [11.9% (95% CI 4.0-25.6%)] had MPA <0.1 ng/mL at week 12; of these, one had MPA <0.1 ng

137 MPA <0.1 ng/mL at week 12; of these, one had MPA <0.1 ng/mL at week 10.

138 MPA <0.1 ng/mL at week 12; of these, one had MPA <0.1 ng/mL at week 10.

139 g effectively and equitably managed, and how MPA management influences substantive outcomes remain un

140 s common in many coastal nations, we ask how MPAs can be designed specifically to improve fisheries y

141 on could induce cellular autophagy, however, MPA also exhibited its inhibitory effect on tunicamycin-

142 strongest predictors of conservation impact: MPAs with adequate staff capacity had ecological effects

143 of malformation (3.9% vs. 2.6%, P = 0.49) in MPA exposed versus unexposed cohorts of children.

144 rld examples of climate change adaptation in MPA planning derive from tropical reefs, highlighting th

145 12, significantly reduced the worm burden in MPA-treated mice undergoing hyperinfection with S. sterc

146 mortality resulting from small increases in MPA size, allowing us to bridge a critical gap between t

147 yperinfection, were found in high numbers in MPA-treated, but not untreated, mice.

148 irectly perceptual and mnemonic responses in MPA and an anterior, connectivity-defined region (CON),

149 Indexed MPA diameter correlated with pulse wave velocity (P=0.04

150 orporate climate change adaptation to inform MPA design.

151 Fish communities inside MPAs were not buffered from these community shifts.

152 tration (target concentration intervention), MPA exposure is successfully controlled and clinical ben

153 tion strategies are rarely incorporated into MPA design and management plans according to the primary

154 ally relevant concentrations of 4.5-4.8 ng/L MPA, DDG and the mixture in eleuthero-embryos and at 43-

155 Large MPAs optimize catch for species heavily harvested for th

156 Self-seeding within higher-latitude MPAs tended to increase, and the role of low-latitude MP

157 ed to increase, and the role of low-latitude MPAs as a sink for urchins changed significantly in cont

158 Thus, locally low MPA density directs local membrane protrusions and stabi

159 ng of the (methyl) methylphosphonic acid ((M)MPA) product to the polyanions, which ultimately inhibit

160 Here we report that many MPAs failed to meet thresholds for effective and equitab

161 However, whether many MPAs are being effectively and equitably managed, and ho

162 The primary outcome measure, MPA concentration (<0.1 ng/mL) at week 12, was assessed

163 1.42 +/- 0.3 g/day and the individual median MPA trough concentration in the time period of anticipat

164 fishes, and sea urchins in 24 Mediterranean MPAs.

165 we here introduce the MetaProteomeAnalyzer (MPA) Portable software.

166 tion problems that arise from mismanagement, MPAs can also benefit fisheries beyond their borders.

167 The comparison between mTORi-CNI and MMF/MPA-CNI did not show differences in acute rejection, mor

168 Efficacy is similar with mTORi + CNI and MMF/MPA-CNI.

169 + CNI compared with regimens containing MMF/MPA or azathioprine with CNI.

170 ween 17% and 46% compared to 0%-26.6% in MMF/MPA groups.

171 ncludes a combination of mycophenolates (MMF/MPA) with a calcineurin inhibitor (CNI).

172 Better graft function was observed using MMF/MPA-CNI than using mTORi + CNI, but this difference was

173 a and leukopenia were more frequent with MMF/MPA-CNI.

174 osphatidylcholine (p < 0.01 at 72 h; 100 muM MPA) which corresponded to the changes in lipid-metaboli

175 < 0.001 at 24 and 72 h; 5, 100, and 250 muM MPA) and upregulation of uridine and cytidine nucleotide

176 tidine nucleotides (p < 0.001 at 24 h; 5 muM MPA) occurred after exposure to MPA.

177 ) in KTR on sirolimus (SRL) + mycophenolate (MPA) or SRL + tacrolimus (Tac), relative to the control-

178 s resulted in nearly 10 million km(2) of new MPAs, a growth of ~360% in a decade.

179 the design and management of existing or new MPAs.

180 Within newer MPAs with intermediate levels of interacting species, S.

181 vity suggest the potential use of this novel MPA-Candida assay in clinical diagnosis and in the contr

182 The median clearance of MPA was 19 681 L/week compared with 12 118 L/week for hi

183 The median clearance of MPA was 19,681 L/week compared to 12,118 L/week for hist

184 leading to sub-therapeutic concentrations of MPA in 12% of women, suggesting that more frequent dosin

185 leading to subtherapeutic concentrations of MPA in 12% of women, suggesting that more frequent dosin

186 h was strongly associated with the degree of MPA distension.

187 food provisioning can be a central driver of MPA design, offering a pathway to strategically conserve

188 ing path nullifying the insulating effect of MPA and also act as a proper immobilization platform for

189 iRNAs could enhance the inhibitory effect of MPA on HCV.

190 gesterone receptor, the preventive effect of MPA was absent in human papillomavirus transgenic mice i

191 own, South Africa, to evaluate the effect of MPA, NET-A, and dexamethasone on Mtb containment in mono

192 Effects of MPA exposure and guanosine supplementation on nucleotide

193 Similarly, the endometria of MPA treated OVX-GPs displayed decreased alphaSMA stainin

194 We demonstrated that the incorporation of MPA functionalized gold nanoparticles (AuNPMPA) as an el

195 omass were only correlated with the level of MPA enforcement; fish density was higher in older, bette

196 However, the mechanism of MPA-mediated inhibition of HCV replication remains to be

197 n in T cells was observed in the presence of MPA, which also broadly upregulated chemokine production

198 The ratio of MPA to aortic size correlated with pulse wave velocity (

199 Cross-reference with previous studies of MPA-associated protein changes widely corroborated these

200 Although 71% of MPAs positively influenced fish populations, these conse

201 Globally, the number and coverage of MPAs are increasing, but MPA implementation lags in many

202 estimates the conservation effectiveness of MPAs for five species of coral reef-associated sharks (T

203 and resources, evaluation of the effects of MPAs is crucial to inform decisions.

204 ss: MPA management processes; the effects of MPAs on fish populations; and relationships between mana

205 Thus, continued global expansion of MPAs without adequate investment in human and financial

206 t estimates of shark conservation impacts of MPAs follow the precautionary approach.

207 ant stocks to derive an optimized network of MPAs globally.

208 ly to change connectivity among a network of MPAs spanning over 1000 km of coastline off the coast of

209 Successful networks of MPAs operate if the space among MPAs is smaller than the

210 However, conservation outcomes of MPAs for mobile and long-lived predators such as sharks

211 Whether the increase outside of MPAs is due to changes in fishing pressure, fisheries ma

212 for sea urchins, connectivity among pairs of MPAs generally decreased in both directions.

213 r kelp, poleward connectivity among pairs of MPAs tended to increase in the future, whereas equatorwa

214 s of connectivity between different pairs of MPAs were noteworthy.

215 nge in predicted connectivity among pairs of MPAs within the network did not change significantly ove

216 y patterns across populations in a series of MPAs in the common yellowhead Jawfish, Opistognathus aur

217 ps the greatest challenge to expanded use of MPAs is the perceived trade-off between protection and f

218 ansplanted men fathered 350 children (155 on MPA/195 not on MPA).

219 fathered 350 children (155 on MPA/195 not on MPA).

220 targeted fish species also increased outside MPAs, although only 27% as rapidly as in the protected a

221 ing and support the continuation of paternal MPA treatment before, during, and after conception.

222 ecovery efficiencies for methyl phosphonate (MPA), nerve agent degradate, and ethylhydrogen dimethylp

223 Plasma MPA concentrations and progesterone were measured pre-do

224 Plasma MPA concentrations and progesterone were measured predos

225 In contrast, CEE plus MPA compared with placebo among 16 608 women with a uter

226 opausal women, hormone therapy with CEE plus MPA for a median of 5.6 years or with CEE alone for a me

227 ty, whereas prior randomized use of CEE plus MPA, compared with placebo, among women who had an intac

228 in the overall pooled cohort; with CEE plus MPA, the HR was 1.02 (95% CI, 0.96-1.08); and with CEE a

229 The CEE-plus-MPA trial was stopped in 2002 after 5.6 years' median in

230 ions and progesterone were measured predose (MPA only) and 2, 4, 6, 8, 10, and 12 weeks after a singl

231 should be replaced by the clinically proven MPA target concentration strategy.

232 We sought to determine whether reliable MPA values can be obtained by simplified procedures.

233 eas selective ablation of estrogen-sensitive MPA neurons demonstrated that these neurons are required

234 e calcium transients from estrogen-sensitive MPA neurons during bouts of hypothermia.

235 ndings suggest a role for estrogen-sensitive MPA neurons in directing the thermoregulatory and metabo

236 Selectively activating estrogen-sensitive MPA neurons was sufficient to drive a coordinated depres

237 Since MPAs can benefit both conservation and fisheries in area

238 alue and/or low harvesting cost, while small MPAs or no closure are best for species lightly harveste

239 better enforced, and -interestingly- smaller MPAs.

240 patient death and graft loss, although SRL + MPA was associated with a lower risk for posttransplant

241 Compared with Tac + MPA, SRL + MPA, and SRL + Tac were associated with higher risks of

242 erostatus to any of the above viruses, SRL + MPA or SRL + Tac was not associated with a different mal

243 more data are needed to evaluate sufficient MPA sizes for protecting populations of species with var

244 Tac), relative to the control-regimen: Tac + MPA.

245 Compared with Tac + MPA, SRL + MPA, and SRL + Tac were associated with highe

246 Compared with Tac + MPA, SRL regimens were associated with higher risks for

247 would need to be enforced as strict no-take MPAs and up to 5 times larger to expect protection of th

248 t and effective enforcement of large no-take MPAs in both coastal and remote locations.

249 e presently under-represented within no-take MPAs that aim to effectively protect marine predators, s

250 In women, taking MPA is teratogenic and may also influence spermatogenesi

251 ad ecological effects 2.9 times greater than MPAs with inadequate capacity.

252 These findings demonstrate that MPA selectively compromises TFV and TAF protection in bl

253 We show that MPA rapidly inhibits Pol III by depleting GTP.

254 Our data suggest that MPA and DDG and their mixtures induce multiple transcrip

255 These results suggest that MPA is efficient in treating progesterone receptor-posit

256 d and genital CD4+ T cells and suggests that MPA may decrease ARV protection in individuals who use A

257 This observation suggests that MPA prevented CIN from progressing to invasive cancer.

258 We found that MPAs exchange migrants likely via intermediate unprotect

259 The MPA is estrogen-sensitive and estrogens also have potent

260 The MPA is, to our knowledge, the first of its kind and offe

261 The MPA network studied would be unable to maintain connecti

262 The MPA-Candida assay can also be coupled to a pan-Fungal as

263 trate that estrogen-sensitive neurons in the MPA can coordinate hypothermia and hypometabolism in mic

264 iol alone, cervical cancer was absent in the MPA-treated mice.

265 We speculate that distension of the MPA may play a major role in limiting full aortic expans

266 nic pressures, they also include much of the MPA network that may provide stepping-stone protection f

267 e of the bilayer and semi circled DDA on the MPA and cysteamine layers were confirmed by the increase

268 nce of an array like semi circled DDA on the MPA and well separated DDA vesicles on the MUDA with var

269 PEG functionalized gold nanoparticles on the MPA surface provided good electron conducting path nulli

270 th candidate host receptors expressed on the MPA.

271 rarily defined fishing mortality outside the MPA's boundaries.

272 conventional methods, demonstrating that the MPA is an important tool for cellular receptor discovery

273 We found that the MPA size that optimizes catch depends strongly on econom

274 or the behavioral response of fishers to the MPA; this approach is distinct from much of the literatu

275 on blood measurements alone is comparable to MPA obtained with combined body counting and blood sampl

276 rmation, and increased p62 level compared to MPA-untreated cells.

277 ant men per whether they had been exposed to MPA or not at time of conception.

278 me of pregnancies fathered by men exposed to MPA.

279 Paternal exposure to MPA did not increase the risk of adverse birth outcomes

280 24 h; 5 muM MPA) occurred after exposure to MPA.

281 the responses of zebrafish (Danio rerio) to MPA, DDG, and their binary mixtures at measured concentr

282 nsible for inhibiting Pol III in response to MPA treatment.

283 We show that upon MPA treatment, the levels of selected Pol III subunits d

284 val revealed better results for mTORi versus MPA in terms of biopsy-proven acute rejection (hazard ra

285 val revealed better results for mTORi versus MPA in terms of biopsy-proven acute rejection [Hazard Ra

286 activated during scene construction than was MPA, whereas MPA was more perceptually responsive than C

287 eir combined influence on food security when MPAs are implemented in an open-access setting.

288 electively extended outward from areas where MPA density was reduced.

289 ur results offer strategic guidance on where MPAs should be placed to support the CBD's overall goal

290 ing scene construction than was MPA, whereas MPA was more perceptually responsive than CON.

291 Here, we investigated the mechanism whereby MPA inhibits RNA polymerase III (Pol III) activity, in b

292 This study investigated whether MPA has an effect on autophagy, a cellular machinery req

293 t weakened fetal membranes (P < 0.05), which MPA inhibited.

294 wing studies which conducted interviews with MPA managers and other conservation practitioners.

295 ere performed on cultured VSMCs treated with MPA or etonogestrel (ETO).

296 c mice bearing CIN lesions were treated with MPA plus 17beta-estradiol.

297 ociate from tRNA genes in yeast treated with MPA, even though there is a sharp decrease in the levels

298 local abundances and fishing pressure, with MPAs required to be 1.6-2.6 times larger to protect the

299 to fishing mortality of sharks found within MPAs as they move outside to adjacent fishing grounds.

300 get of 10% of their geographic ranges within MPAs.